Literature DB >> 2872868

Benzodiazepine antagonist Ro 15-1788 in self-poisoning.

P Lheureux, R Askenasi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2872868

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  5 in total

Review 1.  A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose.

Authors:  A A Weinbroum; R Flaishon; P Sorkine; O Szold; V Rudick
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

2.  Use of flumazenil in intoxicated patients with coma. A double-blind placebo-controlled study in ICU.

Authors:  R Ritz; M Zuber; S Elsasser; G Scollo-Lavizzari
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 3.  Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment.

Authors:  P Gaudreault; J Guay; R L Thivierge; I Verdy
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

Review 4.  Flumazenil. A preliminary review of its benzodiazepine antagonist properties, intrinsic activity and therapeutic use.

Authors:  R N Brogden; K L Goa
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 5.  Pharmacokinetics and clinical use of flumazenil (Ro 15-1788).

Authors:  U Klotz; J Kanto
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.